PDS Biotechnology Corporation Products
PDS’s proprietary Versamune™ technology platform is a broad-based nanoparticle technology with wide applications in the development of novel vaccines to treat and prevent multiple diseases including cancers, viral, bacterial, viral, and parasitic infections. The safe and yet potent technology is being applied to both human and veterinary medicines.